ARTICLE | Company News
Erbitux gets new warning
September 15, 2005 1:30 AM UTC
ImClone (IMCL) and Bristol-Myers (BMY) issued a "Dear Healthcare Provider" letter and updated the label for Erbitux cetuximab to warn of an increased incidence of hypomagnesemia in recent trials and t...